サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1262863

動物用医薬品原薬製造の世界市場レポート 2023年

Veterinary Active Pharmaceutical Ingredients Manufacturing Global Market Report 2023
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.25円
動物用医薬品原薬製造の世界市場レポート 2023年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

動物用医薬品原薬製造の世界市場は、2022年の63億7,000万米ドルから2023年には68億7,000万米ドルへ、CAGR7.8％で成長すると予測されます。ロシア・ウクライナ戦争は、少なくとも短期的には、COVID-19パンデミックからの世界経済回復の可能性を混乱させました。この2国間の戦争は、複数の国への経済制裁、商品価格の高騰、サプライチェーンの混乱につながり、商品やサービス全体にインフレを引き起こし、世界中の多くの市場に影響を与えています。動物用医薬品原薬製造市場は、2027年にはCAGR7.3％で91億1,000万米ドルに成長すると予測されます。

2022年の動物用医薬品原薬製造市場では、北米が最大の地域となりました。動物用医薬品原薬製造市場レポートの対象地域は、アジア太平洋、西欧、中東欧、北米、南米、中東・アフリカです。

ペットの所有者の増加は、今後動物用医薬品原薬製造市場の成長を促進すると予想されます。ペットオーナーとは、ペットの動物を所有したり、飼ったりする個人のことです。ペットの飼い主は、ペットに必要な健康施設を提供し、動物用医薬品の需要を高めています。例えば、香港の英字新聞であるSouth China Morning Postによると、中国のペット所有者は、2019年の6,280万人から2020年には6,294万人に達しました。したがって、ペット所有者の増加は、動物用医薬品原薬製造市場の需要を牽引しています。

目次

第1章 エグゼクティブサマリー

第2章 動物用医薬品原薬製造市場の特徴

第3章 動物用医薬品原薬製造市場の動向と戦略

第4章 動物用医薬品原薬製造市場-マクロ経済シナリオ

  • COVID-19が動物用医薬品原薬製造市場に与える影響
  • ウクライナとロシアの戦争が動物用医薬品原薬製造市場に与える影響
  • 高インフレが動物用医薬品原薬製造市場に与える影響

第5章 動物用医薬品原薬製造の市場規模と成長

  • 世界の動物用医薬品原薬製造市場の実績、2017-2022
    • 市場の促進要因
    • 市場の抑制要因
  • 世界の動物用医薬品原薬製造市場の予測、2022-2027F、2032F
    • 市場の促進要因
    • 市場の抑制要因

第6章 動物用医薬品原薬製造市場セグメンテーション

  • 世界の動物用医薬品原薬製造市場、製品別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 駆虫薬
  • 抗感染症
  • ワクチン
  • NSAID
  • 世界の動物用医薬品原薬製造市場、サービスタイプ別のセグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • インハウス
  • コントラクトアウトソーシング
  • 世界の動物用医薬品原薬製造市場、合成タイプ別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 化学ベースのAPI
  • 生物学的原薬
  • 非常に強力なAPI

第7章 動物用医薬品原薬製造市場の地域および国別分析

  • 世界の動物用医薬品原薬製造市場、地域別、実績と予測、2017-2022、2022-2027F、2032F
  • 世界の動物用医薬品原薬製造市場、国別、実績と予測、2017-2022、2022-2027F、2032F

第8章 アジア太平洋の動物用医薬品原薬製造市場

  • アジア太平洋の動物用医薬品原薬製造市場概要
  • 地域情報, COVID-19の影響,市場情報,背景情報,政府のイニシアチブ,規制,規制機関,主要団体,課税される税,法人税構造,投資,主要企業
  • アジア太平洋の動物用医薬品原薬製造市場
  • アジア太平洋の動物用医薬品原薬製造市場、合成タイプ別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第9章 中国の動物用医薬品原薬製造市場

  • 中国の動物用医薬品原薬製造市場概要
  • 中国の動物用医薬品原薬製造市場、製品別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 中国の動物用医薬品原薬製造市場、合成タイプ別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第10章 インドの動物用医薬品原薬製造市場

  • インドの動物用医薬品原薬製造市場、製品別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • インドの動物用医薬品原薬製造市場、合成タイプ別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第11章 日本の動物用医薬品原薬製造市場

  • 日本の動物用医薬品原薬製造市場、製品別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 日本の動物用医薬品原薬製造市場、合成タイプ別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第12章 オーストラリアの動物用医薬品原薬製造市場

  • オーストラリアの動物用医薬品原薬製造市場、製品別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • オーストラリアの動物用医薬品原薬製造市場、合成タイプ別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第13章 インドネシアの動物用医薬品原薬製造市場

  • インドネシアの動物用医薬品原薬製造市場、製品別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • インドネシアの動物用医薬品原薬製造市場、合成タイプ別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第14章 韓国の動物用医薬品原薬製造市場

  • 韓国の動物用医薬品原薬製造市場、製品別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 韓国の動物用医薬品原薬製造市場、合成タイプ別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第15章 西欧の動物用医薬品原薬製造市場

  • 西欧の動物用医薬品原薬製造市場概要
  • 西欧の動物用医薬品原薬製造市場、製品別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 西欧の動物用医薬品原薬製造市場、合成タイプ別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第16章 英国の動物用医薬品原薬製造市場

  • 英国の動物用医薬品原薬製造市場、製品別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 英国の動物用医薬品原薬製造市場、合成タイプ別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第17章 ドイツの動物用医薬品原薬製造市場

  • ドイツの動物用医薬品原薬製造市場、製品別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • ドイツの動物用医薬品原薬製造市場、合成タイプ別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第18章 フランスの動物用医薬品原薬製造市場

  • フランス動物用医薬品原薬製造市場、製品別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • フランスの動物用医薬品原薬製造市場、合成タイプ別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第19章 東欧の動物用医薬品原薬製造市場

  • 東欧の動物用医薬品原薬製造市場概要
  • 東欧の動物用医薬品原薬製造市場、製品別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 東欧の動物用医薬品原薬製造市場、合成タイプ別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第20章 ロシアの動物用医薬品原薬製造市場

  • ロシアの動物用医薬品原薬製造市場、製品別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • ロシアの動物用医薬品原薬製造市場、合成タイプ別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第21章 北米の動物用医薬品原薬製造市場

  • 北米の動物用医薬品原薬製造市場概要
  • 北米の動物用医薬品原薬製造市場、製品別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 北米の動物用医薬品原薬製造市場、合成タイプ別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第22章 米国の動物用医薬品原薬製造市場

  • 米国の動物用医薬品原薬製造市場概要
  • 米国の動物用医薬品原薬製造市場、製品別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 米国の動物用医薬品原薬製造市場、合成タイプ別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第23章 南米の動物用医薬品原薬製造市場

  • 南米の動物用医薬品原薬製造市場概要
  • 南米の動物用医薬品原薬製造市場、製品別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 南米の動物用医薬品原薬製造市場、合成タイプ別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第24章 ブラジルの動物用医薬品原薬製造市場

  • ブラジルの動物用医薬品原薬製造市場、製品別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • ブラジルの動物用医薬品原薬製造市場、合成タイプ別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第25章 中東の動物用医薬品原薬製造市場

  • 中東の動物用医薬品原薬製造市場概要
  • 中東の動物用医薬品原薬製造市場、製品別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 中東の動物用医薬品原薬製造市場、合成タイプ別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第26章 アフリカの動物用医薬品原薬製造市場

  • アフリカの動物用医薬品原薬製造市場概要
  • アフリカの動物用医薬品原薬製造市場、製品別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • アフリカの動物用医薬品原薬製造市場、合成タイプ別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第27章 動物用医薬品原薬製造市場の競合情勢と企業プロファイル

  • 動物用医薬品原薬製造市場の競合情勢
  • 動物用医薬品原薬製造市場の企業プロファイル
    • Alivira Animal Health Limited
    • Excel Industries Limited
    • Ofichem Group
    • Menadiona SL
    • Afton Pharma

第28章 動物用医薬品原薬製造市場における主要な合併と買収

第29章 動物用医薬品原薬製造市場の将来の見通しと潜在的分析

第30章 付録

目次
Product Code: r5341

“Veterinary Active Pharmaceutical Ingredients Manufacturing Global Market Report 2023 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on veterinary active pharmaceutical ingredients manufacturing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for veterinary active pharmaceutical ingredients manufacturing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The veterinary active pharmaceutical ingredients manufacturing market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Product: Antiparasitic; Anti-Infectives; Vaccines; NSAIDs
  • 2) By Service Type: In House; Contract Outsourcing
  • 3) By Synthesis Type: Chemical Based API; Biological API; Highly Potent API
  • Companies Mentioned: Alivira Animal Health Limited; Excel Industries Limited; Ofichem Group; Menadiona SL; Afton Pharma
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Executive Summary

Major players in the veterinary active pharmaceutical ingredients manufacturing market are: Alivira Animal Health Limited, Excel Industries Limited, Ofichem Group, Menadiona SL, Afton Pharma, Jiangsu Lingyun Pharmaceutical Co Limited, SUANFARMA, NGL Fine-Chem Limited, FIS - Fabbrica Italiana Sintetici SpA, Lupin Limited, Aurobindo Pharma Limited, Albemarle Corporation, Saneca Pharmaceuticals AS, Neuland Laboratories Limited, and Divi's Laboratories Limited.

The global veterinary active pharmaceutical ingredients manufacturing market is expected to grow from $6.37 billion in 2022 to $6.87 billion in 2023 at a compound annual growth rate (CAGR) of 7.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The veterinary active pharmaceutical ingredients manufacturing market is expected to grow to $9.11 billion in 2027 at a CAGR of 7.3%.

The veterinary active pharmaceutical ingredients manufacturing market consists of revenues earned by entities by biologics and bulk drugs that are used to create components in medications which are responsible for the positive veterinary health impacts. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

Veterinary active pharmaceutical ingredients manufacturing refers to API synthesis from raw materials that necessitates multi-step methods using a range of high-tech processing technologies.

North America was the largest region in the veterinary active pharmaceutical ingredients manufacturing market in 2022. The regions covered in the veterinary active pharmaceutical ingredients manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The main products of veterinary active pharmaceutical ingredients manufacturing are anti-infectives, vaccines, and nsaids. Chemical-based API refers to the active ingredients of pharmaceutical medicine that have the desired impact on the body in order to cure a disease. The various service types involved are in house, and contract outsourcing and various synthetic types involved chemical based API, biological API, and highly potent API.

The increasing pet ownerships are expected to propel the growth of the veterinary active pharmaceutical ingredients manufacturing market going forward. Pet owners are individuals who own or adopt a pet animal. The pet owners provide necessary health facilities to the pets which increases the demand for veterinary drugs. For Instance, according to South China Morning Post, a Hong Kong-based English-language newspaper, pet owners in China reached 62.94 million in 2020 - up from 62.8 million in 2019. Therefore, the increasing pet ownership is driving the demand for the veterinary active pharmaceutical ingredients manufacturing market.

Product innovation is a key trend gaining popularity in the veterinary active pharmaceutical ingredient manufacturing market. Major players in the market are focusing on innovative products to sustain their market position. For instance, in June 2021, Lasa Supergenerics Limited, an India-based veterinary active pharmaceutical ingredients (API) manufacturing company, launched Oxyclozanide. Oxyclozanide is a novel anthelmintic that treats and manages fascioliasis, a topical worm infection in ruminants, primarily domestic animals like cattle (particularly buffalos on farms), goats, and sheep. Oxyclozanide is frequently used in the veterinary industry and has enormous potential in domestic and international markets.

In June 2022, Orion Corporation, a Finland-based human and veterinary pharmaceutical industry, acquired Inovet (V.M.D. nv/sa) for an amount of $128.33 million (130 million euros). Through this acquisition, Orion's Veterinary Medicines section will broaden its product portfolio and obtain a foothold in the production animal market, as well as extend its geographical footprint in Western Europe and the export market. Inovet (V.M.D. nv/sa) is a Belgium-based manufacturer of veterinary active pharmaceutical ingredients.

The countries covered in the veterinary active pharmaceutical ingredients manufacturing market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The veterinary active pharmaceutical ingredients manufacturing market research report is one of a series of new reports from The Business Research Company that provides veterinary active pharmaceutical ingredients manufacturing market statistics, including veterinary active pharmaceutical ingredients manufacturing industry global market size, regional shares, competitors with veterinary active pharmaceutical ingredients manufacturing market share, detailed veterinary active pharmaceutical ingredients manufacturing market segments, market trends, and opportunities, and any further data you may need to thrive in the veterinary active pharmaceutical ingredients manufacturing industry. This veterinary active pharmaceutical ingredient manufacturing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Table of Contents

1. Executive Summary

2. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Characteristics

3. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Trends And Strategies

4. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Macro Economic Scenario

  • 4.1. COVID-19 Impact On Veterinary Active Pharmaceutical Ingredients Manufacturing Market
  • 4.2. Ukraine-Russia War Impact On Veterinary Active Pharmaceutical Ingredients Manufacturing Market
  • 4.3. Impact Of High Inflation On Veterinary Active Pharmaceutical Ingredients Manufacturing Market

5. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size And Growth

  • 5.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Historic Market, 2017-2022, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Forecast Market, 2022-2027F, 2032F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Segmentation

  • 6.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Antiparasitic
  • Anti-Infectives
  • Vaccines
  • NSAIDs
  • 6.2. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • In House
  • Contract Outsourcing
  • 6.3. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Chemical Based API
  • Biological API
  • Highly Potent API

7. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Regional And Country Analysis

  • 7.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 7.2. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

8. Asia-Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Market

  • 8.1. Asia-Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 8.3. Asia-Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

9. China Veterinary Active Pharmaceutical Ingredients Manufacturing Market

  • 9.1. China Veterinary Active Pharmaceutical Ingredients Manufacturing Market Overview
  • 9.2. China Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
  • 9.3. China Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

10. India Veterinary Active Pharmaceutical Ingredients Manufacturing Market

  • 10.1. India Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 10.2. India Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

11. Japan Veterinary Active Pharmaceutical Ingredients Manufacturing Market

  • 11.1. Japan Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 11.2. Japan Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

12. Australia Veterinary Active Pharmaceutical Ingredients Manufacturing Market

  • 12.1. Australia Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 12.2. Australia Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

13. Indonesia Veterinary Active Pharmaceutical Ingredients Manufacturing Market

  • 13.1. Indonesia Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 13.2. Indonesia Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

14. South Korea Veterinary Active Pharmaceutical Ingredients Manufacturing Market

  • 14.1. South Korea Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 14.2. South Korea Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

15. Western Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market

  • 15.1. Western Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market Overview
  • 15.2. Western Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 15.3. Western Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

16. UK Veterinary Active Pharmaceutical Ingredients Manufacturing Market

  • 16.1. UK Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 16.2. UK Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

17. Germany Veterinary Active Pharmaceutical Ingredients Manufacturing Market

  • 17.1. Germany Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 17.2. Germany Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

18. France Veterinary Active Pharmaceutical Ingredients Manufacturing Market

  • 18.4. France Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 18.5. France Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

19. Eastern Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market

  • 19.1. Eastern Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market Overview
  • 19.2. Eastern Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 19.3. Eastern Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

20. Russia Veterinary Active Pharmaceutical Ingredients Manufacturing Market

  • 20.1. Russia Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 20.2. Russia Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

21. North America Veterinary Active Pharmaceutical Ingredients Manufacturing Market

  • 21.1. North America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Overview
  • 21.2. North America Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 21.3. North America Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

22. USA Veterinary Active Pharmaceutical Ingredients Manufacturing Market

  • 22.1. USA Veterinary Active Pharmaceutical Ingredients Manufacturing Market Overview
  • 22.2. USA Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 22.3. USA Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

23. South America Veterinary Active Pharmaceutical Ingredients Manufacturing Market

  • 23.1. South America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Overview
  • 23.2. South America Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 23.3. South America Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

24. Brazil Veterinary Active Pharmaceutical Ingredients Manufacturing Market

  • 24.1. Brazil Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 24.2. Brazil Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

25. Middle East Veterinary Active Pharmaceutical Ingredients Manufacturing Market

  • 25.1. Middle East Veterinary Active Pharmaceutical Ingredients Manufacturing Market Overview
  • 25.2. Middle East Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 25.3. Middle East Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

26. Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Market

  • 26.1. Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Market Overview
  • 26.2. Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 26.3. Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

27. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Competitive Landscape And Company Profiles

  • 27.1. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Competitive Landscape
  • 27.2. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Company Profiles
    • 27.2.1. Alivira Animal Health Limited
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Excel Industries Limited
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Ofichem Group
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Menadiona SL
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Afton Pharma
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The Veterinary Active Pharmaceutical Ingredients Manufacturing Market

29. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Future Outlook and Potential Analysis

30. Appendix

  • 30.1. Abbreviations
  • 30.2. Currencies
  • 30.3. Historic And Forecast Inflation Rates
  • 30.4. Research Inquiries
  • 30.5. The Business Research Company
  • 30.6. Copyright And Disclaimer